Paper Details

  1. Home
  2. Paper Details

Antiviral effects of foscarnet and ganciclovir therapy on human immunodeficiency virus p24 antigen in patients with AIDS and cytomegalovirus retinitis. Studies of Ocular Complications of AIDS Research Group in collaboration with AIDS Clinical Trials Group.

Author:

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Multicenter StudyResearch conducted in collaboration with multiple research institutions. It aims to collect a wide range of data and obtain more generalizable results.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, U.S. Gov't, P.H.S.Research funding provided by the Public Health Service (PHS).
Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.

Overview

Both foscarnet and ganciclovir suppressed circulating p24 antigen in HIV-positive patients, which was associated with improved survival.
Paper Details　
Original Abstract of the Article :
To examine whether the prolonged survival seen in patients treated with foscarnet compared with those treated with ganciclovir was due to a direct effect on human immunodeficiency virus (HIV) replication, HIV p24 antigen was measured. Of 71 receiving foscarnet, 54% were p24 antigen-positive at enrol...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1093/infdis/172.3.613

データ提供：米国国立医学図書館（NLM）

AIDS and Cytomegalovirus Retinitis: A Battle on Two Fronts

The fight against AIDS continues to be a critical challenge, with researchers constantly seeking new ways to manage the disease and its complications. This research delves into the effectiveness of antiviral treatments for cytomegalovirus (CMV) retinitis, a serious eye infection that can occur in individuals with AIDS. The study compared the effects of foscarnet and ganciclovir, two antiviral drugs, on both CMV retinitis and HIV replication, revealing insights into the complex interplay of these two conditions.

Double-Edged Sword: Fighting Both AIDS and CMV Retinitis

The study found that both foscarnet and ganciclovir effectively suppressed HIV replication in patients with AIDS and CMV retinitis. This is like a desert warrior fighting a dual battle against two adversaries, using a double-edged sword to combat both threats. The researchers observed a significant decline in the levels of HIV p24 antigen, a marker of HIV replication, in both treatment groups. This suggests that effectively managing CMV retinitis may also have a positive impact on HIV replication.

Hope in the Desert: Managing AIDS and Its Complications

This research offers hope for individuals with AIDS and CMV retinitis, providing evidence that antiviral treatments can effectively manage both conditions. This is like finding a hidden oasis in the vast desert of AIDS, offering a respite from the challenges of the disease and its complications. The study's findings highlight the importance of comprehensive care, addressing both the underlying HIV infection and its associated complications.

Dr.Camel's Conclusion

This research sheds light on the complexities of managing AIDS and its complications. It emphasizes the importance of a multifaceted approach, addressing both the primary infection and its associated conditions. The study offers a glimmer of hope, showcasing the potential of antiviral therapies to effectively manage both AIDS and CMV retinitis.
Date :
  1. Date Completed 1995-10-04
  2. Date Revised 2019-05-12
Further Info :

Pubmed ID

7658051

DOI: Digital Object Identifier

10.1093/infdis/172.3.613

Related Literature

Article Analysis
・Effects of ganciclovir
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.